The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Sclerosis
SELFSEP
1 other identifier
observational
90
1 country
1
Brief Summary
Personal identity is composed of multiple facets of the self that are constructed and nourished through memories of past experiences (i.e., autobiographical memory) and the imagination of events that may occur in the future (i.e., future thinking) . While our previous work has shown that people with relapsing-remitting multiple sclerosis (pwRRMS) have autobiographical memory and future thought disorders, their impact on personal identity has not yet been explored. Based on a cognitive and clinical neuropsychology approach, this research project aims to better understand the cognitive mechanisms involved in the relationship between identity, autobiographical memory and future thinking in pwRRMS. We will examine the extent to which pwRRMS manage to maintain and reshape their identity through life experiences, with a particular interest in the potential integration of the disease as a facet of their identity. In addition, we will explore the positive and/or negative consequences of disease-related identity changes on emotional well-being and quality of life, as well as their links with the duration and severity of the disease. Overall, this research project will contribute to identify new therapeutic levers that can be used for the development of adapted and personalized care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2022
CompletedStudy Start
First participant enrolled
December 7, 2022
CompletedFirst Posted
Study publicly available on registry
December 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2025
CompletedSeptember 6, 2023
September 1, 2023
2 years
December 5, 2022
September 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Relationships between personal identity, autobiographical memory and future thinking
Scores obtained at the I AM and I WILL BE tasks assessing the access, qualitative properties of self-concepts, episodic richness and temporal organization of past and future events around self-concepts (between-group comparisons, pwRRMS versus control group)
15 days
Secondary Outcomes (1)
Relationships between personal identity, psychological functioning and clinical characteristics
15 days
Study Arms (2)
Clinical group
45 individuals with relapsing-remitting multiple sclerosis
Control group
45 individuals with no chronic disease, matched in age, gender and level of education
Interventions
* The clinical group will complete: * the BCcogSEP: a comprehensive neuropsychological examination * the IAM and I WILL BE tasks; experimental neuropsychological tasks to assess autobiographical memory, future thinking and personal identity * A series of questionnaires including the BRIEF COPE, the Connor Davidson Resilience Scale, the Satisfaction with Life Scale and the Hospital Anxiety and Depression Scale, which respectively assess coping strategies, resilience, life satisfaction and anxiety/depression * The control group will complete: * the IAM and I WILL BE tasks; experimental neuropsychological tasks to assess autobiographical memory, future thinking and personal identity * A series of questionnaires including the BRIEF COPE, the Connor Davidson Resilience Scale, the Satisfaction with Life Scale and the Hospital Anxiety and Depression Scale, which respectively assess coping strategies, resilience, life satisfaction and anxiety/depression
Eligibility Criteria
Primary care clinic
You may qualify if:
- Diagnosis of relapsing-remitting MS according to the McDonald's revised diagnostic criteria
- People aged between 18 and 55
- French native speaker
- Access to a computer or tablet, equipped with internet access, a camera and a microphone
- Form of MS other than the relapsing-remitting form
- Neurological history (other than MS for patients), history or current presence of psychiatric disorders (e.g., depression, anxiety disorders, schizophrenia), substance abuse (e.g., alcohol, cannabis; past or present)
- Other diagnosed chronic pathology(ies) (other than MS for patients)
- Severe cognitive impairment
- Persons mentioned in Articles L1121-6 to L1121-8 in the French law (minors, persons deprived of liberty, adults subject to protective measures)
- For the control group:
- People aged between 18 and 55
- Matched in age, gender and level in education
- French native speaker
- Access to a computer or tablet, equipped with internet access, a camera and a microphone
- Neurological history (other than MS for patients), history or current presence of psychiatric disorders (e.g., depression, anxiety disorders, schizophrenia), substance abuse (e.g., alcohol, cannabis; past or present)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre d'Investigation Clinique et Technologique 805lead
- University Paris 8 Vincennes Saint Deniscollaborator
- ARSEP foundationcollaborator
Study Sites (1)
Hopital Raymond Poincaré Garches
Garches, Hauts De Seine, 92380, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra ERNST, PhD
Laboratoire DysCo - Université Paris 8
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 5, 2022
First Posted
December 13, 2022
Study Start
December 7, 2022
Primary Completion
December 7, 2024
Study Completion
June 7, 2025
Last Updated
September 6, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share